60 related articles for article (PubMed ID: 38577570)
21. Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns.
Tuttle RM; Fagin J; Minkowitz G; Wong R; Roman B; Patel S; Untch B; Ganly I; Shaha A; Shah J; Li D; Bach A; Girshman J; Lin O; Cohen M; Cohen JM; Cracchiolo J; Ghossein R; Sabra M; Boucai L; Fish S; Morris L
Thyroid; 2022 Nov; 32(11):1337-1345. PubMed ID: 36178355
[No Abstract] [Full Text] [Related]
22. Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018).
Pasqual E; Sosa JA; Chen Y; Schonfeld SJ; Berrington de González A; Kitahara CM
Thyroid; 2022 Apr; 32(4):397-410. PubMed ID: 35078347
[No Abstract] [Full Text] [Related]
23. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.
Zhong B; Cheng B; Huang X; Xiao Q; Niu Z; Chen YF; Yu Q; Wang W; Wu XJ
Cell Death Dis; 2021 Dec; 13(1):16. PubMed ID: 34930899
[TBL] [Abstract][Full Text] [Related]
24. Management of Sonographically Suspicious Thyroid Nodules 1 cm or Smaller and Candidacy for Active Surveillance: Experience of a Tertiary Center in China.
Hu YL; Cao XY; Zhou YR; Ye XH; Wang JX; Li X; Rong R; Shen MP; Wu XH
Endocr Pract; 2021 Sep; 27(9):903-911. PubMed ID: 33607263
[TBL] [Abstract][Full Text] [Related]
25. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
Molinaro E; Campopiano MC; Pieruzzi L; Matrone A; Agate L; Bottici V; Viola D; Cappagli V; Valerio L; Giani C; Puleo L; Lorusso L; Piaggi P; Torregrossa L; Basolo F; Vitti P; Tuttle RM; Elisei R
J Clin Endocrinol Metab; 2020 Mar; 105(3):e172-80. PubMed ID: 31652318
[TBL] [Abstract][Full Text] [Related]
26. Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.
Miyauchi A; Kudo T; Ito Y; Oda H; Yamamoto M; Sasai H; Higashiyama T; Masuoka H; Fukushima M; Kihara M; Miya A
Surgery; 2019 Jan; 165(1):25-30. PubMed ID: 30413323
[TBL] [Abstract][Full Text] [Related]
27. Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance.
Miyauchi A; Kudo T; Ito Y; Oda H; Sasai H; Higashiyama T; Fukushima M; Masuoka H; Kihara M; Miya A
Surgery; 2018 Jan; 163(1):48-52. PubMed ID: 29103582
[TBL] [Abstract][Full Text] [Related]
28. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
[TBL] [Abstract][Full Text] [Related]
29. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
[TBL] [Abstract][Full Text] [Related]
30. Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid.
Miyauchi A
World J Surg; 2016 Mar; 40(3):516-22. PubMed ID: 26744340
[TBL] [Abstract][Full Text] [Related]
31. Natural History of Asymptomatic Papillary Thyroid Microcarcinoma: Time-Dependent Changes in Calcification and Vascularity During Active Surveillance.
Fukuoka O; Sugitani I; Ebina A; Toda K; Kawabata K; Yamada K
World J Surg; 2016 Mar; 40(3):529-37. PubMed ID: 26581368
[TBL] [Abstract][Full Text] [Related]
32. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
33. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
34. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.
Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
Thyroid; 2014 Jan; 24(1):27-34. PubMed ID: 24001104
[TBL] [Abstract][Full Text] [Related]
35. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
[TBL] [Abstract][Full Text] [Related]
36. Occult papillary carcinoma of the thyroid gland: a study of 140 cases observed in a 30-year period.
WOOLNER LB; LEMMON ML; BEAHRS OH; BLACK BM; KEATING FR
J Clin Endocrinol Metab; 1960 Jan; 20():89-105. PubMed ID: 13845950
[No Abstract] [Full Text] [Related]
37. Observations on growth rates of human tumors.
COLLINS VP; LOEFFLER RK; TIVEY H
Am J Roentgenol Radium Ther Nucl Med; 1956 Nov; 76(5):988-1000. PubMed ID: 13362715
[No Abstract] [Full Text] [Related]
38. Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China.
Le K; Jin L; Zhong F; Huang X; Zhou L; Zhou J; Xie L
Front Endocrinol (Lausanne); 2024; 15():1359621. PubMed ID: 38577570
[TBL] [Abstract][Full Text] [Related]
39. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
40. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma.
Jeon MJ; Kim WG; Kim TY; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2021 Aug; 36(4):717-724. PubMed ID: 34379969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
